The notional value of Bitcoin futures relative to spot prices has dropped to 0.24x, the lowest in two years, indicating a significant decline in leveraged speculative trading. This reduction reflects a broader market shift away from high-risk futures contracts, with open interest and volume on major platforms like CME falling sharply. While leverage persists in perpetual contracts and options, the shrinking futures market reduces arbitrage opportunities and price discovery, potentially making spot prices more volatile. This trend suggests institutional interest in Bitcoin futures is waning, requiring new catalysts to revive participation.
Bitcoin futures notional value has dropped to its lowest in two years. For readers following cryptocurrency markets, here is Pluang's market snapshot as of Sep 30, 2026 04:03 WIB: Among 50 major cryptocurrencies, 29 rose and 20 fell today. Notable movers include SNX (Synthetix) up 5.18% with 99% buy orders, KSM (Kusama) up 4.89% with 94% sell orders, and COMP (Compound) up 4.62% with a near-even buy/sell split.
GameStop's CEO Ryan Cohen and other executives have made significant insider purchases of millions of shares, showing strong confidence in the company's future despite recent stock price volatility. These buys were active decisions, not pre-scheduled...
Concentrix Corporation reported mixed Q3 2026 results with earnings per share of $2.92, beating analyst expectations of $2.71. However, its revenue of $2.45 billion slightly missed the forecast of $2.48 billion. The company achieved a record free cas...
Accenture is set to report Q3 2026 earnings on October 1, with analysts forecasting $18.03 billion in revenue, a 5.6% increase year-over-year, and earnings per share around $3.18. The growth is fueled by strong demand for AI services, with 100 new ad...
Iovance Biotherapeutics shares jumped 31.48% after raising its 2026 revenue forecast, driven by strong demand for its cancer immunotherapy Amtagvi. SoundThinking's stock rose 50.09% following an acquisition agreement with Transom Capital Group, offer...
Shares of uniQure dropped 37.33% following mixed clinical data for its Huntington's disease gene therapy. Fair Isaac fell 26.52% after U.S. regulators expanded the use of competitor VantageScore in mortgage credit scoring, threatening its market posi...
